Aberdeen Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,233
| Closed | -$2.25M | – | 922 |
|
|
2024
Q2 | $2.25M | Sell |
8,233
-430
| -5% | -$117K | ﹤0.01% | 740 |
|
|
2024
Q1 | $3M | Sell |
8,663
-129
| -1% | -$44.6K | 0.01% | 740 |
|
|
2023
Q4 | $2.84M | Buy |
8,792
+3,588
| +69% | +$1.16M | 0.01% | 748 |
|
|
2023
Q3 | $1.87M | Sell |
5,204
-261
| -5% | -$93.6K | ﹤0.01% | 703 |
|
|
2023
Q2 | $2.07M | Sell |
5,465
-234
| -4% | -$88.7K | ﹤0.01% | 718 |
|
|
2023
Q1 | $2.73M | Sell |
5,699
-2,566
| -31% | -$1.23M | 0.01% | 685 |
|
|
2022
Q4 | $3.48M | Buy |
8,265
+3,085
| +60% | +$1.3M | 0.01% | 614 |
|
|
2022
Q3 | $2.16M | Buy |
5,180
+31
| +0.6% | +$12.9K | 0.01% | 697 |
|
|
2022
Q2 | $2.56M | Sell |
5,149
-186
| -3% | -$92.4K | 0.01% | 681 |
|
|
2022
Q1 | $3.06M | Sell |
5,335
-995
| -16% | -$570K | 0.01% | 676 |
|
|
2021
Q4 | $4.78M | Sell |
6,330
-744
| -11% | -$562K | 0.01% | 645 |
|
|
2021
Q3 | $5.3M | Sell |
7,074
-2,293
| -24% | -$1.72M | 0.01% | 643 |
|
|
2021
Q2 | $6.04M | Sell |
9,367
-180
| -2% | -$116K | 0.01% | 606 |
|
|
2021
Q1 | $5.45M | Buy |
9,547
+325
| +4% | +$186K | 0.01% | 629 |
|
|
2020
Q4 | $5.38M | Buy |
9,222
+2,578
| +39% | +$1.5M | 0.01% | 586 |
|
|
2020
Q3 | $3.43M | Buy |
6,644
+524
| +9% | +$270K | 0.01% | 629 |
|
|
2020
Q2 | $2.76M | Buy |
6,120
+4,809
| +367% | +$2.17M | 0.01% | 656 |
|
|
2020
Q1 | $460K | Buy |
1,311
+171
| +15% | +$60K | ﹤0.01% | 843 |
|
|
2019
Q4 | $422K | Buy |
+1,140
| New | +$422K | ﹤0.01% | 895 |
|